4.3 Article

Peripheral metabolism of [18F]FDDNP and cerebral uptake of its labelled metabolites

期刊

NUCLEAR MEDICINE AND BIOLOGY
卷 35, 期 8, 页码 869-874

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.nucmedbio.2008.09.002

关键词

[(18)F]FDDNP; Amyloid; Metabolism; BBB transport; PET

资金

  1. DiMI [LSHB-CT-2005-512146]

向作者/读者索取更多资源

[(18)F]FDDNP is a positron emission tomography (PET) tracer for determining amyloid plaques and neurofibrillary tangles in the brain in vivo. in order to quantify binding of this tracer properly, a metabolite-corrected plasma input function is required. The purpose of the present Study was to develop a sensitive method for measuring [(18)F]FDDNP and its radiolabelled metabolites in plasma. The second aim was to assess whether these radiolabelled metabolites enter the brain. In humans, there was extensive metabolism of [(18)F]FDDNP. After 10 min, more than 90% of plasma radioactivity was identified as polar (18)F-labelled fragments, probably formed from N-dealkylation of [(18)F]FDDNP. These labelled metabolites were reproduced in vitro using human hepatocytes. PET studies in rats showed that these polar metabolites can penetrate the blood-brain barrier and result in uniform brain uptake. (c) 2008 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据